Oct. 5, 2020 11:30 UTC
GOLDEN, Colo.--(BUSINESS WIRE)-- Reven Holdings, Inc. (Reven) is a privately held clinical stage biotechnology and pharmaceutical company dedicated to the discovery and development of novel treatment platforms for cancer, viral illnessesincluding COVID-19and inflammatory disorders.
Reven is planning to initiate a randomized, double-blind, placebo-controlled, multi-institutional clinical trial of its lead anti-inflammatory/anti-oxidant investigational drug product Rejuveinix (RJX) in the treatment of COVID-19. The upcoming clinical trial is designed to evaluate the safety and efficacy of RJX in COVID-19 patients.
Reven today announced that three new members with extensive experience and knowledge in clinical research and quality assurance have joined its multi-disciplinary team to work on the COVID-19 clinical project:
Nancy Oehlke has assumed the role of Manager of Regulatory Affairs and Quality Assurance. Nancy has 20+ years of experience in drug development, Good Manufacturing Practice (GMP) / Good Laboratory Practice (GLP) compliance, regulatory aspects of drug product manufacturing and testing, and clinical research.
Renae Townsend has assumed the role of Director of Clinical Operations and Jenny Daniels has assumed the role of Director of Clinical Quality Assurance. Both Renae and Jenny have 15+ years of Good Clinical Practice (GCP), clinical research and clinical monitoring experience.
These new team members will help us provide sponsor oversight for the services rendered by the clinical research organizations (CRO) and other vendors who will support our clinical RJX program and execution of the clinical trial. I am excited to welcome these very experienced new members to Reven. I look forward to the opportunity to work side by side with them as we try to diligently advance the clinical development of RJX, said Fatih Uckun, MD PhD, Chief Medical Officer and Chief Scientific Officer of Reven.
Our IND (Investigational New Drug) application package for COVID-19 is completed and we are planning to roll out our clinical program against COVID-19 in the coming month, said Michael Volk, Director and Chief Strategy Officer of Reven.
Our new team members each will have a very important role in our efforts aimed at evaluating the clinical impact potential of RJX, added Peter Lange, CEO of Reven.
About Rejuveinix (RJX) RJX is an intravenous (IV) formulation of a patented first-in-class pharmaceutical composition containing a specific mixture of anti-oxidant and anti-inflammatory ingredients that is being developed for more effective treatment of patients with inflammatory disorders, including COVID-19 patients with viral sepsis and acute respiratory distress syndrome (ARDS). The clinical safety and tolerability of RJX was confirmed in a recently completed double blind, placebo-controlled Phase 1 dose-escalation study in healthy volunteers (ClinicalTrials.gov Identifier: NCT03680105).
About Reven Holdings, Inc. Reven Holdings, Inc., a Delaware corporation, through its Golden/Colorado-based operating company Reven, LLC, is developing new drugs for difficult-to-treat diseases. As a clinical stage biopharmaceutical company, Revens overarching goal is to develop effective treatments for serious health conditions caused by infectious, inflammatory, cardiovascular, and metabolic diseases. Its lead product, RJX, is being developed as a treatment platform against complications of COVID-19, sepsis, cardiovascular diseases, and diabetes.
About Dr. Fatih Uckun, M.D., Ph.D, Chief Medical Officer of Reven. Dr. Uckun is an Active Member of the American Society for Clinical Investigation (ASCI), an honor society for physician-scientists, and an active member of several professional organizations. He earned his doctoral degrees at University of Heidelberg in Germany and completed his residency training in Pediatrics, fellowship training in Hematology/Oncology/Blood and Bone Marrow Stem Cell Transplantation, as well as postdoctoral research training in immunology and microbiology at the University of Minnesota in the US.
Dr. Uckun has more than 30 years of professional experience in developmental therapeutics and biopharmaceuticals in oncology/immuno-oncology as well as infectious diseases and immunology. In addition, Dr. Uckun has deep knowledge and 20+ years of experience in treatment of infectious diseases and their complications. In particular, he has extensive experience in viral, fungal, and bacterial infections of immunocompromised hosts, septic shock, ARDS as well as systemic capillary leak syndrome and cytokine release syndrome (CRS). Dr. Uckun served as a Defense Advanced Research Projects Agency (DARPA)-funded principal investigator and directed a universal virus neutralizer program project as part of a countermeasures initiative against viruses that can be used as bioweapons and therefore pose a biothreat for our national security. Prior to joining Reven, Dr. Uckun was a Vice President, Clinical Strategy Lead, Oncology-Hematology and Member of the COVID-19 Task Force at Worldwide Clinical Trials.
Dr. Uckun worked 11 years as a Professor of Bone Marrow Transplantation, Therapeutic Radiology-Radiation Oncology, Pharmacology, and Pediatrics as well as Director of the Biotherapy Institute at the University of Minnesota, where he became the first recipient of the Endowed Hughes Chair in Biotherapy. He worked 6 years as a Professor and Head of Translational Research in Leukemia and Lymphoma of the CCBD and a Principal Investigator of the Stem Cell-Regenerative Medicine Initiative at the at the University of Southern California. During that time, Dr. Uckun served as the Chair of the Biotargeting Working Group for the National Cancer Institute (NCI)s Nanotechnology Alliance in Cancer.
He has held executive positions in multiple biotechnology companies and has extensive regulatory experience. He has published more than 500 peer-reviewed papers, received numerous awards, and served as a member of several medical journal editorial boards and NIH grant review/special emphasis panels. Website: https://www.linkedin.com/in/fatihuckun/
Revens Cautionary Note on Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, included in this communication regarding strategy, future operations, future financial position, prospects, plans and objectives of management are forward-looking statements. Words such as may, on-track, expect, anticipate hope, vision, optimism, design, exciting, promising, will, conviction, estimate, intend, believe and similar expressions are intended to identify forward-looking statements. Forward-looking statements contained in this press release include, but are not limited to, statements about future plans, the progress, timing, clinical development, scope and success of future clinical trials, the reporting of clinical data for the companys product candidates and the potential use of the companys product candidates to treat various disease indications. Each of these forward-looking statements involves risks and uncertainties, and actual results may differ materially from these forward-looking statements. Many factors may cause differences between current expectations and actual results, including unexpected safety or efficacy data observed during preclinical or clinical studies, clinical trial site activation or enrollment rates that are lower than expected, changes in expected or existing market competition, changes in the regulatory environment, failure of collaborators to support or advance collaborations or product candidates, and unexpected litigation or other disputes. These risks are not exhaustive; the company faces known and unknown risks, including the risk factors described in the companys periodic SEC filings. Forward-looking statements are based on expectations and assumptions as of the date of this press release. Except as required by law, the company does not assume any obligation to update forward-looking statements contained herein to reflect any change in expectations, whether as a result of new information regarding future events, or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201005005298/en/
Link:
Reven Strengthens Its Clinical Team With Three New Members - BioSpace
- Spotlight on Cancer Stem Cell Research – Stem Cell Cafe [Last Updated On: May 22nd, 2011] [Originally Added On: May 22nd, 2011]
- Stem Cells and Controversy – Stem Cell Cafe [Last Updated On: June 28th, 2011] [Originally Added On: June 28th, 2011]
- Lisa Ray asks you to join Stem Cell City – Stem Cell Cafe [Last Updated On: June 28th, 2011] [Originally Added On: June 28th, 2011]
- Michael Savage...Embryonic Stell Cell Research...Part 2 [Last Updated On: August 4th, 2011] [Originally Added On: August 4th, 2011]
- Michael Savage...Embryonic Stell Cell Research...Part 3 [Last Updated On: August 6th, 2011] [Originally Added On: August 6th, 2011]
- Stem Cell Therapy at City of Hope: Building on the Promise [Last Updated On: August 8th, 2011] [Originally Added On: August 8th, 2011]
- Obama on Embryonic Stem Cell Research [Last Updated On: August 9th, 2011] [Originally Added On: August 9th, 2011]
- Medical Treatment by Stem Cells Myth or Reality? Episode 2 - Video [Last Updated On: October 15th, 2011] [Originally Added On: October 15th, 2011]
- Stem Cells Regenerate New Finger! - Video [Last Updated On: October 17th, 2011] [Originally Added On: October 17th, 2011]
- MS Patient After Stem Cell Therapy - Video [Last Updated On: October 19th, 2011] [Originally Added On: October 19th, 2011]
- Stem Cell Transplant - Video [Last Updated On: October 19th, 2011] [Originally Added On: October 19th, 2011]
- The EU and stem cell research - Video [Last Updated On: October 20th, 2011] [Originally Added On: October 20th, 2011]
- Dr. Oz to Oprah and Michael J Fox: "The stem cell debate is dead." - Video [Last Updated On: December 8th, 2011] [Originally Added On: December 8th, 2011]
- Politics: President Obama on Stem Cell Research - Video [Last Updated On: December 9th, 2011] [Originally Added On: December 9th, 2011]
- Be still my beating stem cell heart - Video [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- Adult Stem Cell vs Embryonic Stem Cell Research Ethics Video - Video [Last Updated On: December 19th, 2011] [Originally Added On: December 19th, 2011]
- A new hair loss treatment using stem cells ethically, safely and effectively. - Video [Last Updated On: December 31st, 2011] [Originally Added On: December 31st, 2011]
- U-M Would Have To Report Data On Stell Cell Research In New House Bill [Last Updated On: March 30th, 2012] [Originally Added On: March 30th, 2012]
- Stem Cells Restore Man's Vision | The art of cord blood banking [Last Updated On: January 4th, 2013] [Originally Added On: January 4th, 2013]
- Cancer Stem Cells – Video – Stem Cell Cafe [Last Updated On: January 7th, 2013] [Originally Added On: January 7th, 2013]
- Research and Markets: Stem Cell Therapy Market in Asia-Pacific to ... [Last Updated On: January 13th, 2013] [Originally Added On: January 13th, 2013]
- Genea Stem Cells (GSC): 25 new disease specific pluripotent stem ... [Last Updated On: January 14th, 2013] [Originally Added On: January 14th, 2013]
- Court lifts cloud over embryonic stem cells – Stem Cell Cafe [Last Updated On: January 16th, 2013] [Originally Added On: January 16th, 2013]
- Drug targets leukemia stem cells – Stem Cell Cafe [Last Updated On: January 18th, 2013] [Originally Added On: January 18th, 2013]
- CRF to sponsor 8th International Conference on ... - Stem Cell Cafe [Last Updated On: January 19th, 2013] [Originally Added On: January 19th, 2013]
- Bacteria Can Morph Host Cells Into Stem Cells – Stem Cell Cafe [Last Updated On: January 21st, 2013] [Originally Added On: January 21st, 2013]
- Springhill Medical Group-What is Stem Cell Therapy? - Stem Cell Cafe [Last Updated On: January 22nd, 2013] [Originally Added On: January 22nd, 2013]
- Stem Cells – A Medical Dictionary, Bibliography, And Annotated ... [Last Updated On: January 23rd, 2013] [Originally Added On: January 23rd, 2013]
- StemCells, Inc. to Present at Phacilitate Cell ... - Stem Cell Cafe [Last Updated On: January 24th, 2013] [Originally Added On: January 24th, 2013]
- Stem cells aid recovery from stroke – Stem Cell Cafe [Last Updated On: January 28th, 2013] [Originally Added On: January 28th, 2013]
- Adult Stem Cells Regrow cut off Finger! – Video – Stem Cell Cafe [Last Updated On: February 4th, 2013] [Originally Added On: February 4th, 2013]
- Stem cells is no hype but it is a better hope: Experts – Stem Cell Cafe [Last Updated On: February 6th, 2013] [Originally Added On: February 6th, 2013]
- 3D printing with stem cells could lead to printable organs – Stem ... [Last Updated On: February 6th, 2013] [Originally Added On: February 6th, 2013]
- Monell scientists identify taste stem cells on the tongue – Stem Cell ... [Last Updated On: February 7th, 2013] [Originally Added On: February 7th, 2013]
- Scientists Say 3D Printing Can Create Stem Cells – Video – Stem ... [Last Updated On: February 7th, 2013] [Originally Added On: February 7th, 2013]
- Fish stem cells could light the way to optical breakthroughs – Stem ... [Last Updated On: February 17th, 2013] [Originally Added On: February 17th, 2013]
- Signaling factors may be key to stem cells' healing abilities ... [Last Updated On: February 18th, 2013] [Originally Added On: February 18th, 2013]
- Regenerative medicine and Stem cells Partnering Terms and ... [Last Updated On: February 19th, 2013] [Originally Added On: February 19th, 2013]
- Market Research Report — Therapeutic ... - Stem Cell Cafe [Last Updated On: February 22nd, 2013] [Originally Added On: February 22nd, 2013]
- Cell therapy: New mouse model promises to advance research on ... [Last Updated On: February 22nd, 2013] [Originally Added On: February 22nd, 2013]
- Florida Hospital Pepin Heart Institute, USF partner ... - Stem Cell Cafe [Last Updated On: February 23rd, 2013] [Originally Added On: February 23rd, 2013]
- Schistosome stem cells could explain how the worms survive for so ... [Last Updated On: February 24th, 2013] [Originally Added On: February 24th, 2013]
- Egg cells from Stell Cells: A breakthrough in fertility research | Bionic ... [Last Updated On: February 26th, 2013] [Originally Added On: February 26th, 2013]
- BioMarin Licenses Factor VIII Gene Therapy ... - Stem Cell Cafe [Last Updated On: February 26th, 2013] [Originally Added On: February 26th, 2013]
- 'Holy Grail' of stem cell research discovered – Stem Cell Clinic ... [Last Updated On: March 1st, 2013] [Originally Added On: March 1st, 2013]
- OHSU Doernbecher Scientists First To Grow Liver Stem Cells In ... [Last Updated On: March 1st, 2013] [Originally Added On: March 1st, 2013]
- FRC's Dr. David Prentice Congratulates Kansas ... - Stem Cell Cafe [Last Updated On: March 5th, 2013] [Originally Added On: March 5th, 2013]
- UCLA researchers explore cutting edge of stem cells – Stem Cell Cafe [Last Updated On: March 10th, 2013] [Originally Added On: March 10th, 2013]
- Study finds stem cells in deer antler – Stem Cell Cafe [Last Updated On: March 21st, 2013] [Originally Added On: March 21st, 2013]
- IDIBELL signs agreement with Histocell to use ... - Stem Cell Cafe [Last Updated On: March 29th, 2013] [Originally Added On: March 29th, 2013]
- Stem Cell Therapy Market in Asia-Pacific to 2018 Market Research ... [Last Updated On: March 31st, 2013] [Originally Added On: March 31st, 2013]
- Researchers first to use common virus to 'fortify' adult stem cells ... [Last Updated On: April 2nd, 2013] [Originally Added On: April 2nd, 2013]
- Stem Cells Harvested From Human Gut For First Time - Stem Cell Cafe [Last Updated On: April 6th, 2013] [Originally Added On: April 6th, 2013]
- "Nanokicking" Stem Cells Offers Cheaper And Easier Way To Grow ... [Last Updated On: April 7th, 2013] [Originally Added On: April 7th, 2013]
- Adhesive force differences enable separation of stem cells to ... [Last Updated On: April 8th, 2013] [Originally Added On: April 8th, 2013]
- Embryonic-like stem cells collected from adults to grow bone – Stem ... [Last Updated On: April 8th, 2013] [Originally Added On: April 8th, 2013]
- Pro-lifers eye Kansas for top study of stem cells; no embryo use at ... [Last Updated On: April 12th, 2013] [Originally Added On: April 12th, 2013]
- StemCells, Inc. Enters Agreement to Receive $19.3 ... - Stem Cell Cafe [Last Updated On: April 12th, 2013] [Originally Added On: April 12th, 2013]
- 'Smart' stem cells repair damage from heart failure – Stem Cell Cafe [Last Updated On: April 12th, 2013] [Originally Added On: April 12th, 2013]
- First-in-humans study introduces next generation ... - Stem Cell Cafe [Last Updated On: April 13th, 2013] [Originally Added On: April 13th, 2013]
- Stem Cells Show Promise in Heart Failure Patients – Stem Cell Cafe [Last Updated On: April 15th, 2013] [Originally Added On: April 15th, 2013]
- IDIBELL signs agreement with Histocell to use … – Stem Cell Cafe ... [Last Updated On: April 16th, 2013] [Originally Added On: April 16th, 2013]
- Circuit Court OKs Funding of Embryonic Stem Cell Research ... [Last Updated On: April 16th, 2013] [Originally Added On: April 16th, 2013]
- Pros And Cons Of Stem Cell Research [Last Updated On: April 16th, 2013] [Originally Added On: April 16th, 2013]
- Adult stem cells offer ethical, effective cures, speakers say ... - First [Last Updated On: April 17th, 2013] [Originally Added On: April 17th, 2013]
- Preliminary Research, Led By Dr. Vincent Giampapa, Finds Aged ... [Last Updated On: April 17th, 2013] [Originally Added On: April 17th, 2013]
- Voices Against Brain Cancer Comments on New Study Claiming Fat ... [Last Updated On: April 20th, 2013] [Originally Added On: April 20th, 2013]
- UCLA Researchers Develop New Method for Purifying Stem Cells ... [Last Updated On: April 23rd, 2013] [Originally Added On: April 23rd, 2013]
- Scientist identifies protein molecule used to ... - Stem Cell Cafe [Last Updated On: April 25th, 2013] [Originally Added On: April 25th, 2013]
- Human Stem Cells Injected In Mice Restore Memory, Learning ... [Last Updated On: April 25th, 2013] [Originally Added On: April 25th, 2013]
- Explore the Forefront of iPS Cell Research ... - Stem Cell Cafe [Last Updated On: April 26th, 2013] [Originally Added On: April 26th, 2013]
- Stem Cell Therapy Market in Asia-Pacific to 2018 ... [Last Updated On: April 28th, 2013] [Originally Added On: April 28th, 2013]
- Dr. Farshid Guilak: Can stem cells help those with arthritis? – Stem ... [Last Updated On: April 28th, 2013] [Originally Added On: April 28th, 2013]
- AKC Canine Health Foundation Releases Webinar ... - Stem Cell Cafe [Last Updated On: April 28th, 2013] [Originally Added On: April 28th, 2013]
- German stem cells give new life to cancer patient in Gujarat – Stem ... [Last Updated On: April 29th, 2013] [Originally Added On: April 29th, 2013]
- Stem Cell Therapy Market in Asia-Pacific to 2018 ... - Stem Cell Cafe [Last Updated On: April 30th, 2013] [Originally Added On: April 30th, 2013]
- Study confirms that mesenchymal stem cells may help treat cancer ... [Last Updated On: April 30th, 2013] [Originally Added On: April 30th, 2013]
- Adults lack stem cells for making new eggs, research shows – Stem ... [Last Updated On: April 30th, 2013] [Originally Added On: April 30th, 2013]
- Stemedica Issued U.S. Patent For Ectodermal Stem Cells – Stem ... [Last Updated On: April 30th, 2013] [Originally Added On: April 30th, 2013]
- Clarifying the effect of stem cell therapy on cancer – Stem Cell Cafe [Last Updated On: May 2nd, 2013] [Originally Added On: May 2nd, 2013]